Tech Company Financing Transactions
Calviri Funding Round
Calviri closed a $2.3 million Seed funding round on 4/3/2020. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/3/2020
Transaction Type
Venture Equity
Amount
$2,250,000
Round
Seed
Investors
private investors (Jacque Sokolov)
Proceeds Purpose
The company intends to use the funds to demonstrate the strengths of its technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8606 S Dorsey Ln.
Tempe, AZ 85284
USA
Tempe, AZ 85284
USA
Phone
Website
Email Address
Overview
Calviri's mission is to provide affordable products worldwide that will end deaths from cancer by combining a unique, highly immunogenic source of neoantigens with a peptide array platform. On our course to eradicate cancer we will develop new diagnostic and therapeutic products, and then preventative vaccines that will stop cancer from starting.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Johnston
VP - Bus. Development
Edward Rady
VP - Finance
Douglas Redding
VP - Operations
Chris Diehnelt
VP - R & D
Kathryn Sykes
Browse more venture capital transactions:
Prev: 4/2/2020: Plum Lending venture capital transaction
Next: 4/3/2020: MedGenome venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs